Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: Results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial

Michael E. Weinblatt, Clifton O. Bingham, Alan M. Mendelsohn, Lilianne Kim, Michael Mack, Jiandong Lu, Daniel Baker, Rene Westhovens

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Fingerprint

Dive into the research topics of 'Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: Results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds